BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25686482)

  • 1. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
    Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
    Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.
    Dhakal S; Corbin KS; Milano MT; Philip A; Sahasrabudhe D; Jones C; Constine LS
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):940-5. PubMed ID: 21277105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.
    Baumann BC; Bernstein KA; DeLaney TF; Simone CB; Kolker JD; Choy E; Levin WP; Weber KL; Muniappan A; Berman AT; Staddon A; Hartner L; Van Tine B; Hirbe A; Glatstein E; Hahn SM; Nagda SN; Chen YL
    J Surg Oncol; 2020 Oct; 122(5):877-883. PubMed ID: 32588468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection.
    Baumann BC; Nagda SN; Kolker JD; Levin WP; Weber KL; Berman AT; Staddon A; Hartner L; Hahn SM; Glatstein E; Simone CB
    J Surg Oncol; 2016 Jul; 114(1):65-9. PubMed ID: 27111504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas.
    Frakulli R; Salvi F; Balestrini D; Parisi A; Palombarini M; Cammelli S; Rocca M; Salone M; Longhi A; Ferrari S; Morganti AG; Frezza G
    Anticancer Res; 2015 Oct; 35(10):5581-6. PubMed ID: 26408729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.
    Kim SS; Song SY; Kwak J; Ahn SD; Kim JH; Lee JS; Kim WS; Kim SW; Choi EK
    Lung Cancer; 2013 Feb; 79(2):161-6. PubMed ID: 23182662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results after resection for soft tissue sarcoma pulmonary metastases.
    García Franco CE; Algarra SM; Ezcurra AT; Guillén-Grima F; San-Julián M; Mindán JP; Buxalleu WT
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):223-6. PubMed ID: 19454417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques.
    Palma DA; Senan S; Haasbeek CJ; Verbakel WF; Vincent A; Lagerwaard F
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):506-13. PubMed ID: 20584582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Lindner LH; Litière S; Sleijfer S; Benson C; Italiano A; Kasper B; Messiou C; Gelderblom H; Wardelmann E; Le Cesne A; Blay JY; Marreaud S; Hindi N; Desar IME; Gronchi A; van der Graaf WTA
    Int J Cancer; 2018 Jun; 142(12):2610-2620. PubMed ID: 29383713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiotherapy Versus Metastasectomy in Patients With Pulmonary Metastases From Soft Tissue Sarcoma.
    Tetta C; Londero F; Micali LR; Parise G; Algargoush AT; Algargoosh M; Albisinni U; Maessen JG; Gelsomino S
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):303-315. PubMed ID: 32024603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases.
    Spratt DE; Arevalo-Perez J; Leeman JE; Gerber NK; Folkert M; Taunk NK; Alektiar KM; Karimi S; Lyo JK; Tap WD; Bilsky MH; Laufer I; Yamada Y; Osborne JR
    Spine J; 2016 Mar; 16(3):291-8. PubMed ID: 26325017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
    Leeman JE; Bilsky M; Laufer I; Folkert MR; Taunk NK; Osborne JR; Arevalo-Perez J; Zatcky J; Alektiar KM; Yamada Y; Spratt DE
    J Neurosurg Spine; 2016 Jul; 25(1):52-8. PubMed ID: 26943256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for unbiopsied early-stage lung cancer: a multi-institutional analysis.
    Harkenrider MM; Bertke MH; Dunlap NE
    Am J Clin Oncol; 2014 Aug; 37(4):337-42. PubMed ID: 23660597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.
    Parsai S; Sedor G; Smile TD; Scott J; Ochocki A; Vassil N; Zahler S; Angelov L; Chao ST; Qi P; Anderson P; Murphy ES
    Am J Clin Oncol; 2021 Mar; 44(3):126-130. PubMed ID: 33405479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT).
    Altoos B; Amini A; Yacoub M; Bourlon MT; Kessler EE; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
    Radiat Oncol; 2015 Oct; 10():218. PubMed ID: 26510665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.
    Scorsetti M; Clerici E; Navarria P; D'Agostino G; Piergallini L; De Rose F; Ascolese A; Tozzi A; Iftode C; Villa E; Comito T; Franzese C; Mancosu P; Tomatis S; Cozzi L
    Br J Radiol; 2015 Sep; 88(1053):20150111. PubMed ID: 26183933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
    Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
    J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases.
    Boehling NS; Grosshans DR; Allen PK; McAleer MF; Burton AW; Azeem S; Rhines LD; Chang EL
    J Neurosurg Spine; 2012 Apr; 16(4):379-86. PubMed ID: 22225488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.